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property of ECP is unclear. It has been hypothesized that ECP cytotoxicity is due to destabilization of lipid membranes of target cells (6) , and the degree of cytotoxicity is dependent on the cellular concentration (7) . The binding of ECP to target cells has been attributed to its high arginine content (estimated pI = 10.8), which facilitates the interaction between ECP and negatively charged molecules on the cell surface (7, 8) . Recently, we found that binding and endocytosis of ECP into bronchial epithelial cells were greatly dependent on the cell surface glycosaminoglycan (GAG), specifically heparan sulfate proteoglycans (HSPG) (9) . The cytotoxicity of ECP was severely reduced toward cell lines with heparan sulfate (HS) deficiency. The primers used were as follows: mt1 forward, supplemented with heat-inactivated 10% fetal bovine serum (Gibco/Invitrogen, Carlsbad, CA).
Fluorescence-assisted carbohydrate electrophoresis (FACE)-Synthetic heparin
oligosaccharide from the degree of polymerization (dp) 3 to 9 ( Figure 1 
where #F max is the maximum relative fluorescence The decrease in the free LMWH signal was monitored as ECP concentration was increased ( Figure 2A ). Subsequently, the dependence of ECP binding on heparin size was examined in the presence of synthetic heparin oligosaccharides dp3 to dp9 using LMWH as a positive control. It was apparent that dp5 served as the shortest heparin fragment that retained the ability to bind ECP ( Figure 2B ). Furthermore, we tested a potent heparanase inhibitor (PI-88), undergoing clinical trials for its anti-angiogenic and anti-metastatic effects (22, 23) , that contains a mixture of highly sulfated mannose-containing dito hexasaccharides (24, 25) . Interestingly, this heparin mimetic could also bind ECP ( Figure 2B ). derived from RNase1 was tested using cell ELISA assay. As expected, similar to the TAT peptide, C1 and D1 peptides bound to the cell surface, whereas R1 peptide was devoid of such function ( Figure 6B ).
Competitive inhibition of ECP

Interaction of synthetic peptides with LMWH.
The ability of C1 to directly interact with LMWH was further investigated by FACE analysis. As cell line ( Figure 9 , Table III Figure   10A , B). ECP internalizaiton was reduced when co-injection with heparin was carried out ( Figure   10C ). For the negative control, no MBP signal was detected in tracheo-and broncho-epithelial cells [ (Figure 10D ), despite the MBP signal that could be detected in circulating blood ( Figure   10D ).
Discussion
Here we provide the first direct evidence that 
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